The role of positive feedback loops involving anti-dsDNA and anti-anti-dsDNA antibodies in autoimmune glomerulonephritis

被引:0
|
作者
Arazi, A. [1 ,2 ]
Neumann, A. U. [1 ,2 ]
机构
[1] Bar Ilan Univ, Fac Life Sci, Ramat Gan, Israel
[2] Humboldt Univ, Inst Theoret Biol, D-10099 Berlin, Germany
关键词
Autoimmune glomerulonephritis; Systemic lupus erythematosus; Autoimmune inflammation; Anti-idiotypic antibodies; TLR9; SYSTEMIC-LUPUS-ERYTHEMATOSUS; IDIOTYPIC NETWORK MODEL; STATIONARY STATES; DNA; DISEASE; MICE; AUTOANTIBODIES; DYNAMICS; OSCILLATIONS; SUPPRESSION;
D O I
10.1016/j.jtbi.2012.09.017
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Autoimmune glomerulonephritis (GN) is a potentially life-threatening renal inflammation occurring in a significant percentage of systemic lupus erythematosus (SLE) patients. It has been suggested that GN develops and persists due to a positive feedback loop, in which inflammation is promoted by the deposition in the kidney of immune complexes (IC) containing double-stranded DNA (dsDNA) and autoantibodies specific to it, leading to cellular death, additional release to circulation of dsDNA, continuous activation of dsDNA-specific autoreactive B cells and further formation of IC. We have recently presented a generic model exploring the dynamics of IC-mediated autoimmune inflammatory diseases, applicable also to GN. Here we extend this model by incorporating into it a specific B cell response targeting anti-dsDNA antibodies a phenomenon whose occurrence in SLE patients is well-supported empirically. We show that this model retains the main results found for the original model studied, particularly with regard to the sensitivity of the steady state properties to changes in parameter values, while capturing some disease-specific observations found in GN patients which are unaccountable using our previous model. In particular, the extended model explains the findings that this inflammation can be ameliorated by treatment without lowering the level of anti-dsDNA antibodies. Moreover, it can account for the inverse oscillations of anti-dsDNA and anti-anti-dsDNA antibodies, previously reported in lupus patients. Finally, it can be used to suggest a possible explanation to the so-called regulatory role of TLR9, found in murine models of lupus; i.e., the fact that the knockdown of this DNA-sensing receptor leads, as expected, to a decrease in the level of anti-dsDNA antibodies, but at the same time results in a counter-intuitive amplification of the autoreactive immune response and an exacerbated inflammation. Several predictions can be derived from the analysis of the presented model, allowing its experimental verification. (C) 2012 Published by Elsevier Ltd.
引用
收藏
页码:8 / 22
页数:15
相关论文
共 50 条
  • [41] Anti-dsDNA Is Associated with Favorable Prognosis in Myasthenia Gravis: A Retrospective Study
    Li, Shiyin
    Chen, Jiaxin
    Yang, Xu
    Huang, Xin
    Wang, Haiyan
    Feng, Huiyu
    ACTA NEUROLOGICA SCANDINAVICA, 2023, 2023
  • [42] Systematic review of anti-dsDNA testing for systemic lupus erythematosus: A meta-analysis of the diagnostic test specificity of an anti-dsDNA fluorescence enzyme immunoassay
    Orme, Michelle E.
    Voreck, Anja
    Aksouh, Redha
    Ramsey-Goldman, Rosalind
    Schreurs, Marco W. J.
    AUTOIMMUNITY REVIEWS, 2021, 20 (11)
  • [43] Association of IgA anti-dsDNA antibodies with vasculitis and disease activity in systemic lupus erythematosus
    Witte, T
    Hartung, K
    Matthias, T
    Sachse, C
    Fricke, M
    Deicher, H
    Kalden, JR
    Lakomek, HJ
    Peter, HH
    Schmidt, RE
    RHEUMATOLOGY INTERNATIONAL, 1998, 18 (02) : 63 - 69
  • [44] PHEMA cryogel for in-vitro removal of anti-dsDNA antibodies from SLE plasma
    Ozgur, Erdogan
    Bereli, Nilay
    Turkmen, Deniz
    Unal, Serhat
    Denizli, Adil
    MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2011, 31 (05): : 915 - 920
  • [45] Anti-dsDNA antibody testing by Farr and ELISA techniques is not equivalent
    Neogi, Tuhina
    Gladman, Dafna D.
    Ibanez, Dominique
    Urowitz, Murray
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (09) : 1785 - 1788
  • [46] Clinical evaluation of a new automated anti-dsDNA fluorescent immunoassay
    Hernando, M
    González, C
    Sánchez, A
    Guevara, P
    Navajo, JA
    Papisch, W
    González-Buitrago, JM
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2002, 40 (10) : 1056 - 1060
  • [47] ANTI-DSDNA AND SM AUTOANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    MARTINEZCORDERO, E
    MARTINEZMIRANDA, E
    NEGRETEGARCIA, MC
    PADILLA, A
    LEON, DEA
    CLINICAL RHEUMATOLOGY, 1992, 11 (03) : 341 - 345
  • [48] Association between anti-dsDNA titre increase and thymoma relapse
    Cavagna, L.
    Prisco, E.
    Montecucco, C.
    Caporali, R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (03) : 599 - 600
  • [49] Association of coexisting anti-ribosomal P and anti-dsDNA antibodies with histology and renal prognosis in lupus nephritis patients
    Wakamatsu, Ayako
    Sato, Hiroe
    Kaneko, Yoshikatsu
    Cho, Takamasa
    Ito, Yumi
    Kurosawa, Yoichi
    Hasegawa, Eriko
    Kobayashi, Daisuke
    Nakatsue, Takeshi
    Kuroda, Takeshi
    Suzuki, Yoshiki
    Uchiumi, Toshio
    Narita, Ichiei
    LUPUS, 2021, 30 (03) : 448 - 458
  • [50] Heterogeneity of anti-dsDNA antibodies in their cross-reaction with ribosomal P protein
    Takeda, I
    Rayno, K
    Wolfson-Reichlin, M
    Reichlin, M
    JOURNAL OF AUTOIMMUNITY, 1999, 13 (04) : 423 - 428